DPP4 and Cognitive impairment: Several DM hyperglycemia ameliorating drugs such as the peroxisome proliferator-activated receptor gamma (PPARγ) agonist, glucagon-like peptide-1 (GLP-1) and dipeptidylpeptidase-4 inhibitor were reported to improve the cognitive deficits in DM patients [49–51].